stella
beta
SCRT Followed by Camrelizumab Combined With Fluzoparib and Chemotherapy as Neoadjuvant Therapy for LARC — Stella
Recruiting
Back to Colorectal Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Tongji hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei
View full record on ClinicalTrials.gov